Roger Greenberg, MD, PhD, is the J. Samuel Staub, M.D. Professor at the University of Pennsylvania Perelman School of Medicine, where he serves as Director of the Penn Center for Genome Integrity and Basic Science Director at the Basser Center for BRCA. Dr. Greenberg’s laboratory investigates basic mechanisms of genome integrity and their impact on cancer etiology and response to therapy. His major research interests center on (1) DNA damage repair by the breast cancer suppressor proteins BRCA1 and BRCA2, (2) targetable vulnerabilities in homologous recombination deficient cells, (3) mechanisms of alternative lengthening of telomeres, and (4) DNA damage dependent activation of immune responses to cancer. His group has contributed basic discoveries and translation advances in each of these areas.
Dr. Greenberg was elected to the American Society of Clinical Investigation and American Association of Physicians and is a recipient of numerous awards and keynote lecture invitations.
Roger Greenberg, MD, PhD, is the J. Samuel Staub, M.D. Professor at the University of Pennsylvania Perelman School of Medicine, where he serves as Director of the Penn Center for Genome Integrity and Basic Science Director at the Basser Center for BRCA. Dr. Greenberg’s laboratory investigates basic mechanisms of genome integrity and their impact on cancer etiology and response to therapy. His major research interests center on (1) DNA damage repair by the breast cancer suppressor proteins BRCA1 and BRCA2, (2) targetable vulnerabilities in homologous recombination deficient cells, (3) mechanisms of alternative lengthening of telomeres, and (4) DNA damage dependent activation of immune responses to cancer. His group has contributed basic discoveries and translation advances in each of these areas.
Dr. Greenberg was elected to the American Society of Clinical Investigation and American Association of Physicians and is a recipient of numerous awards and keynote lecture invitations.